26-000767 nextseq 1000/2000 P2 xleap-SBS reagent kit (300 cycles)
Ended Awarded Last action
- Contract number
- 75N90026F00001
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $149,193
Award facts
- Contract value 100% obligated
- $149,192.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $149,193 |
About this award
The NIH Clinical Center awarded a delivery order (26-000767) to Illumina, Inc. for NextSeq 1000/2000 P2 XLEAP-SBS Reagent Kits (300 cycles) on December 23, 2025, with a ceiling value of $149,192.82 and a firm fixed price structure. This is a non-set-aside contract with performance completion targeted for September 30, 2026, and will be fulfilled from Illumina's San Diego, California facility. The delivery order procures specialized sequencing reagent kits designed for use with Illumina's NextSeq sequencing platforms, which are commonly deployed across federal research institutions for genomic analysis and next-generation sequencing applications.
Illumina, a leading biotechnology company headquartered in San Diego, specializes in genetic sequencing and genomic analysis technologies and serves as a prime contractor to numerous federal agencies including the NIH, CDC, USDA, VA, and FDA. The company maintains significant federal contracting relationships, including a $45 million Indefinite Delivery Contract with the USDA through June 2030, and has demonstrated specialized technological capabilities that support advanced DNA and RNA sequencing research across civilian federal agencies. This reagent kit delivery order supports the NIH Clinical Center's genomic research and diagnostic capabilities through procurement of consumables for its existing NextSeq instrumentation.
Quick answers
Who was awarded contract 75N90026F00001?
75N90026F00001 was awarded to Illumina, Inc. by NIH Clinical Center (National Institutes of Health) on December 23, 2025.
How much is contract 75N90026F00001 worth?
The government has obligated $149,193 on 75N90026F00001.
Is contract 75N90026F00001 an order under another contract?
Yes. 75N90026F00001 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N90026F00001 competed?
The extent of competition for 75N90026F00001 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award